BioInvent: BioInvent International: BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3

LUND, SWEDEN / ACCESS Newswire / April 8, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-c...